ALDEYRA THERAPEUTICS INC's ticker is ALDX and the CUSIP is 01438T106. A total of 113 filers reported holding ALDEYRA THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 0.99 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $553,000 | +389.4% | 124,299 | +338.3% | 0.00% | – |
| Q4 2021 | $113,000 | -58.8% | 28,357 | -9.1% | 0.00% | – |
| Q3 2021 | $274,000 | -79.7% | 31,184 | -73.8% | 0.00% | -100.0% |
| Q2 2021 | $1,348,000 | +323.9% | 118,940 | +344.3% | 0.00% | – |
| Q1 2021 | $318,000 | +283.1% | 26,769 | +121.6% | 0.00% | – |
| Q4 2020 | $83,000 | -27.8% | 12,080 | -22.0% | 0.00% | – |
| Q3 2020 | $115,000 | +69.1% | 15,493 | -5.2% | 0.00% | – |
| Q2 2020 | $68,000 | +47.8% | 16,338 | -11.5% | 0.00% | – |
| Q1 2020 | $46,000 | -70.5% | 18,459 | -31.2% | 0.00% | – |
| Q4 2019 | $156,000 | +85.7% | 26,828 | +68.5% | 0.00% | – |
| Q3 2019 | $84,000 | -89.1% | 15,921 | -82.8% | 0.00% | -100.0% |
| Q4 2018 | $770,000 | -28.0% | 92,816 | +19.7% | 0.00% | 0.0% |
| Q3 2018 | $1,070,000 | – | 77,518 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Prosight Management, LP | 908,488 | $6,232,000 | 2.88% |
| Knoll Capital Management, LLC | 569,405 | $3,906,000 | 2.66% |
| Mesirow Financial Investment Management, Inc. | 64,698 | $443,828,000 | 1.40% |
| Ghost Tree Capital, LLC | 650,000 | $4,459,000 | 0.99% |
| Johnson & Johnson Innovation - JJDC, Inc. | 594,834 | $4,081,000 | 0.53% |
| Perceptive Advisors | 6,285,458 | $43,118,000 | 0.46% |
| Affinity Asset Advisors, LLC | 100,000 | $686,000 | 0.36% |
| ACUTA CAPITAL PARTNERS, LLC | 192,500 | $1,321,000 | 0.36% |
| Avidity Partners Management LP | 1,435,000 | $9,844,000 | 0.32% |
| APOGEM CAPITAL LLC | 55,821 | $383,000 | 0.26% |